Amino acid substitutions of thyroid hormone receptor-β at codon 435 with resistance to thyroid hormone selectively alter homodimer formation

Endocrinology

Volumn 137, Issue 10, 1996, Pages 4082-4086

  Nomura, Yoshio ^a   Nagaya, Takashi ^a   Tsukaguchi, Hiroyasu ^b   Takamatsu, Junta ^c   Seo, Hisao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CODON; DIMERIZATION; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; GENE CLUSTER; GENETIC TRANSFECTION; HORMONE ACTION; HORMONE RESISTANCE; HORMONE RESPONSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029763409     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.10.8828460     Document Type: Article

References (32)

1. Lazar MA 1993 Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14:184-193
2. Refetoff S, Weiss RE, Usala SJ 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399
3. Chatterjee VK, Nagaya T, Madison LD, Datta S, Rentoumis A, Jameson JL 1991 Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. J Clin Invest 87:1977-1984
4. Nagaya T, Madison LD, Jameson JL 1992 Thyroid hormone receptor mutants that cause resistance to thyroid hormone. Evidence for receptor competition for DNA sequences in target genes. J Biol Chem 267:13014-13019
5. Nagaya T, Jameson JL 1993 Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J Biol Chem 268:15766-15771
6. Refetoff S, Weiss RE, Usala SJ, Hayashi Y 1994 The syndromes of resistance to thyroid hormone: update. In: Endocrine Reviews Monographs. The Endocrine Society, Bethesda, vol 3:336-343
7. Au-Fliegner M, Helmer E, Casanova J, Raaka BM, Samuels HH 1993 The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Biol 13:5725-5737
8. Tsukaguchi H, Yoshimasa Y, Fujimoto K, Ishii H, Yamamoto T, Yoshimasa T, Yagura T, Takamatsu J 1995 Three novel mutations of thyroid hormone receptor β gene in unrelated patients with resistance to thyroid hormone. Two mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance. J Clin Endocrinol Metab 80:3613-3616
9. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
10. Forman BM, Yang CR, Stanley F, Casanova J, Samuels HH 1988 c-erbA protooncogenes mediate thyroid hormone-dependent and independent regulation of the rat growth hormone and prolactin genes. Mol Endocrinol 2:902-911
11. Wood WM, Kao MY, Gordon DF, Ridgway EC 1989 Thyroid hormone regulates the mouse thyrotropin β-subunit gene promoter in transfected primary thyrotropes. J Biol Chem 264:14840-14847
12. Chatterjee VK, Lee JK, Rentoumis A, Jameson JL 1989 Negative regulation of the thyroid-stimulating hormone a gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci USA 86:9114-9118
13. Nagaya T, Eberhardt NL, Jameson JL 1993 Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab 77:982-990
14. Graham FL, van der Eb A 1973 A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467
15. Gorman C, Moffat LF, Howard BH 1982 Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol Cell Biol 2:1044-1051
16. deWet JR, Wood KV, DeLuca M, Helinski DR, Subramani S 1987 Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7:725-737
17. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Gamier JM, Mader S, Chambon P 1992 Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395
18. Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M 1992 Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446
19. 3 signaling. Nature 355:446-449
20. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXR β: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
21. Perlmann T, Rangarajan PN, Umesono K, Evans RM 1993 Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev 7:1411-1422
22. Forman BM, Yang CR, Au M, Casanova J, Ghysdael J, Samuels HH 1989 A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol 3:1610-1626
23. Marks MS, Hallenbeck PL, Nagata T, Segars JH, Appella E, Nikodem VM, Ozato K 1992 H-2RIIBP (RXR β) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J 11:1419-1435
24. Nagaya T, Jameson JL 1993 Distinct dimerization domains provide antagonist pathways for thyroid hormone receptor action. J Biol Chem 268:24278-24282
25. Flynn TR, Hollenberg AN, Cohen O, Menke JB, Usala SJ, Tollin S, Hegarty MK, Wondisford FE 1994 A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem 269:32713-32716
26. Collingwood TN, Adams M, Tone Y, Chatterjee VK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277
27. Yen PM, Sugawara A, Refetoff S, Chin WW 1992 New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. J Clin Invest 90:1825-1831
28. Hao E, Menke JB, Smith AM, Jones C, Geffer ME, Hershman JM, Wuerth JP, Samuels HH, Ways DK, Usala SJ 1994 Divergent dimerization properties of mutant β1 thyroid hormone receptors are associated with different dominant negative activities. Mol Endocrinol 8:841-851
29. Piedrafita FJ, Bendikt I, Ortiz MA, Phahl M 1995 Thyroid hormone receptor homodimers can function as ligand-sensitive repressors. Mol Endocrinol 9:563-578
30. Kitajima K, Nagaya T, Jameson JL 1995 Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization. Thyroid 5:343-353
31. 3 response element-dependent dominant negative potency. J Clin Invest 92:1986-1993
32. Zavacki AM, Harney JW, Brent GA, Larsen PR 1993 Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol Endocrinol 7:1319-1330